These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1663860)

  • 1. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group.
    Bombardier C; Raboud J
    Control Clin Trials; 1991 Aug; 12(4 Suppl):243S-256S. PubMed ID: 1663860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
    Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
    Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures.
    Morgan GJ
    Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial.
    Buchbinder R; Bombardier C; Yeung M; Tugwell P
    Arthritis Rheum; 1995 Nov; 38(11):1568-80. PubMed ID: 7488277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis.
    Kaplan RM; Anderson JP; Wu AW; Mathews WC; Kozin F; Orenstein D
    Med Care; 1989 Mar; 27(3 Suppl):S27-43. PubMed ID: 2921885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
    Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
    J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.
    Tuttleman M; Pillemer SR; Tilley BC; Fowler SE; Buckley LM; Alarcón GS; Trentham DE; Neuner R; Clegg DO; Leisen JC; Heyse SP
    J Rheumatol; 1997 Oct; 24(10):1910-5. PubMed ID: 9330931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis.
    Glennås A; Kvien TK; Andrup O; Clarke-Jenssen O; Karstensen B; Brodin U
    Br J Rheumatol; 1997 Aug; 36(8):870-7. PubMed ID: 9291856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.
    Carette S; Calin A; McCafferty JP; Wallin BA
    Arthritis Rheum; 1989 Feb; 32(2):158-65. PubMed ID: 2645874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost effectiveness of auranofin: results of a randomized clinical trial.
    Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
    J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.
    Johnsen V; Borg G; Trang LE; Berg E; Brodin U
    Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of two different Health Assessment Questionnaires in Turkish rheumatoid arthritis population and assessment of the associations with disability.
    Senerdem N; Gül A; Koniçe M; Aral O; Ocal L; Inanç M; Yüzbaşioğlu N
    Clin Rheumatol; 1999; 18(1):33-7. PubMed ID: 10088946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Clin Rheumatol; 1990 Sep; 9(3):356-61. PubMed ID: 2261735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial.
    Borg G; Allander E; Berg E; Brodin U; From A; Trang L
    J Rheumatol; 1991 Jul; 18(7):1015-20. PubMed ID: 1920306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
    Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F
    Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index.
    Salaffi F; Stancati A; Neri R; Grassi W; Bombardieri S
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S31-42. PubMed ID: 16273783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
    Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
    Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.